Lowest dose of progesterone for HRT. - Reddit

Why is progesterone included in HRT?

The uterine lining (endometrium) responds to estrogen stimulation by proliferating. In a natural menstrual cycle, progesterone produced during the luteal phase counteracts this proliferation, causing the endometrium to shed or remain stable. When postmenopausal women take systemic estrogen without a progestogen, the endometrium is exposed to ongoing stimulation without the balancing progesterone effect.

Unopposed estrogen increases the risk of endometrial hyperplasia, a precancerous thickening of the uterine lining, and eventually endometrial cancer. This was well-established in the 1970s and is the primary reason progestogen is included in HRT for women who have a uterus. Adding a progestogen protects the endometrium and eliminates most of this risk when used at adequate dose and duration.

Women who have had a hysterectomy do not have a uterus and therefore do not need progestogen for endometrial protection. Estrogen-only HRT is generally appropriate for them.

What is the difference between bioidentical progesterone and synthetic progestins?

“Progesterone” and “progestin” are not interchangeable terms, and the distinction matters for dosing, side effects, and safety signals.

Bioidentical micronized progesterone (available as Prometrium or as a compounded formulation) is chemically identical to the progesterone produced by the human body. It has been extensively studied, particularly in the French E3N cohort study, which found a more favorable breast tissue safety profile compared to synthetic progestins. Its most prominent side effect is drowsiness, which is why most protocols dose it at bedtime — this becomes a feature rather than a drawback for many patients who struggle with perimenopausal sleep disruption.

Synthetic progestinssuch as medroxyprogesterone acetate (MPA), norethindrone acetate, and levonorgestrel bind to progesterone receptors but also have off-target activity at androgen, glucocorticoid, and mineralocorticoid receptors. This different receptor profile is responsible for their different side effect profile, including more pronounced effects on mood, libido, and possibly cardiovascular and breast tissue compared to bioidentical progesterone. The Women’s Health Initiative (WHI) study used conjugated equine estrogens plus MPA, and much of the early concern about HRT and breast cancer risk originated from that trial’s data on the progestin arm.

What is the lowest effective dose of progesterone for HRT?

The minimum dose of progesterone that adequately protects the endometrium is not a fixed number. It is a function of:

• Estrogen dose and route: Higher estrogen doses and systemic routes (oral, transdermal) produce more endometrial stimulation. Higher stimulation requires more progestogen to counteract it. Vaginal estrogen used for local symptoms only (at low doses) is generally considered not to require systemic progestogen protection because it has minimal systemic absorption.
• Continuous vs. cyclic regimen: Continuous combined regimens (progestogen taken every day) can use lower daily doses because the endometrium is never given a rest period of unopposed estrogen stimulation. Cyclic regimens (progestogen for 10 to 14 days per month) typically use higher daily doses for a shorter duration.
• Individual endometrial sensitivity: Some women’s endometria are more sensitive to estrogen stimulation than others. This is assessed clinically through breakthrough bleeding patterns and, when indicated, ultrasound or biopsy.

Standard dosing reference ranges

For oral micronized progesterone (OMP):

• Continuous combined: 100 mg nightly is the most commonly cited minimum for adequate protection at standard estrogen doses. Some protocols use 200 mg in the first year and step down to 100 mg once the endometrium has been stabilized.
• Sequential / cyclic: 200 mg nightly for 12 to 14 days per cycle is the reference dose for cyclic regimens.

These are reference points, not universal prescriptions. Your clinician may adjust based on your response, any breakthrough bleeding, and follow-up monitoring.

Reference ranges drawn from clinical literature and prescribing guidelines. Individual protocols vary; consult your clinician.

What progesterone routes and formulations exist beyond oral?

Oral micronized progesterone is not the only option. Clinicians increasingly use alternative routes, particularly for patients who want to minimize the drowsiness side effect or who prefer to avoid oral tablets:

• Vaginal progesterone: Vaginal administration achieves high local endometrial concentrations with relatively lower systemic levels (the “first uterine pass” effect). This is an option for women who experience side effects from oral progesterone or who prefer to minimize systemic exposure. Compounded vaginal progesterone suppositories or gels are commonly used in this context.
• Transdermal or topical progesterone: Over-the-counter progesterone creams are widely available but poorly absorbed. Studies consistently show that OTC-strength topical progesterone does not reliably protect the endometrium at standard estrogen doses. Prescription-strength compounded transdermal formulations achieve higher absorption but are variable and not well standardized. This is an area where clinical caution is appropriate.
• Progesterone-releasing IUDs: Levonorgestrel-releasing IUDs (Mirena) provide local endometrial protection and are sometimes used in combination with systemic estrogen. They eliminate the need for systemic progestogen but involve a procedure for insertion and removal.

What are the side effects of progesterone, and how does dosing affect them?

Most of the unwanted side effects of progesterone in HRT are dose-related and formulation-dependent:

• Drowsiness: Primarily a feature of oral micronized progesterone. Taking it at bedtime converts this from a daytime liability into a sleep aid. Lower doses in continuous regimens reduce daytime carryover.
• Bloating and fluid retention: More common with synthetic progestins than bioidentical progesterone. Vaginal delivery reduces systemic exposure and tends to minimize these effects.
• Mood effects: Both progesterone and progestins can affect mood in some individuals. This is an area of significant individual variability. Some women feel calmer on progesterone (via neurosteroid pathways); others experience irritability or low mood. Dosing adjustments and route changes can help if this is an issue.
• Irregular bleeding: Breakthrough or irregular bleeding, particularly in the first months of a continuous combined regimen, is common while the endometrium stabilizes. Persistent or heavy bleeding should be evaluated.

How is progesterone dosing monitored and adjusted?

Progesterone dosing in HRT is not a set-and-forget decision. Ongoing monitoring informs whether the chosen dose is adequate and tolerable:

• Breakthrough bleeding should be reported to your clinician and evaluated. It can indicate insufficient endometrial protection or other causes.
• Pelvic ultrasound to assess endometrial thickness is appropriate if bleeding patterns are abnormal, or periodically in higher-risk situations.
• Serum progesterone levels can be measured but are not a direct proxy for endometrial protection, particularly with vaginal administration (where serum levels are low but local uterine concentration is high).
• Annual clinician review of the HRT regimen allows dose optimization as your hormonal needs change over time.

For context on HRT as part of a broader hormone optimization program, including how HRT may support body composition, see the related articles in our library.

Frequently asked questions